Economics of vaccinating U.S. adults ≥60 years-old against respiratory syncytial virus updated summary comparing models from: GSK, Pfizer and University of Michigan-CDC
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Economics of vaccinating U.S. adults ≥60 years-old against respiratory syncytial virus updated summary comparing models from: GSK, Pfizer and University of Michigan-CDC

Filetype[PDF-1.22 MB]


English

Supporting Files

  • No Additional Files
More +

Related Documents

You May Also Like

Checkout today's featured content at stacks.cdc.gov